Immunobiology Of Natural Killer Cells : Volume 1 book cover
1st Edition

Immunobiology Of Natural Killer Cells
Volume 1

ISBN 9780367254841
Published February 17, 2022 by CRC Press
213 Pages

FREE Standard Shipping
USD $65.00

Prices & shipping based on shipping country


Book Description

First published in 1986: This book contributes to the advancing knowledge of reads in the field of NK cells, and will be helpful as a teaching device.

Table of Contents

1. Assays for NK Cell Cytotoxciity; Their Values and Pitfalls

Hugh F. Pross, Denis Callewaert, and Peter Rubin

2. Separation and Characterization of Phenotypically Distinct Subsets of NK Cells

Paola Allavena and John R. Otaldo

3. Ultrastructure and Cytochemistry of the Human Large Granular Lymphocytes

Manlio Ferrarini and Carlo E. Grossi

4. Phylogeny and Ontogeny of NK Cells

Cherylyn A. Savary and Eva Lotzova

5. Tissue and Organ Distribution of NK Cells

Craig W. Reynolds and Jerold M. Ward

6. Genetic Control of NK Cell Activity in Rodents

Edward A. Clark

7. Phenotype, Functional Heterogenecity, and Lineage of Natural Killer Cells

Sylvia B. Pollack

8. Target Cell Structures, Recognition Sites, and the Mechanism of NK Cytotoxicity

Tatsuo Kiyohara et al.

9. Natural Killer Cytotoxic Factors (NKCF) Role in Cell-Mediated

Benjamin Bonavida and Susan C. Wright

10. Characteristics of Cultured NK Cells

Robert C. Burton

11. Lectin-Dependent Killer Cells

Benjamin Bonavida

12. MLC-Induced Cytoxicity as a Model for the Development and Regulation of NK Cytotoxicity

Paul J. D’Amore and Sidney H. Golub

13. LGL Lymphoproliferative Diseases in Man and Experimental Animals: The Characteristics of These Cells and Their Potential Experimental Uses

Craig W. Reynolds and Jerrold M. Ward

View More



Dr. Eva Lotzova is Professor of Immunology, Chief of the Division of Immunologenetics at the University of Texas System Cancer, M.D. Anderson Hospital and Tumor Institute, Houston.

Dr. Ronald B. Herberman, formerly Chief of Biological Therapeutics Branch and Acting Associate Director for the Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, Frederick, Maryland.